8VE-27943-15790
4 vaccinations
5 coded responses
28 check-ins
5 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 068 / CT
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Registered in v-safe
-
2021-03-07
Dose 1 — Pfizer-BioNTech
-
2021-03-07
Health check-in — day 0, dose 1Feeling: Good · Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-03-08
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Good · Site: PainFree text: Feeling great! So grateful for the vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-21
- 2021-03-28
-
2021-03-29
Dose 2 — Pfizer-BioNTech
-
2021-04-04
Survey response — days 1–6 daily, dose 2MedDRA: Pain — Feeling: GoodFree text: Slightly sore are on March 30MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
-
2021-05-03
Survey response — day 35, dose 2MedDRA: Rash, Rash erythematous, Rash pruritic, Self-medication — Feeling: GoodFree text: I had a rash on various parts of my body on April 26 - 30. I believe it was a mild viral infection. My spouse had the same symptoms about 6 days after my symptoms. OTC cortisone relieved symptoms (itching, redness).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-10
- 2021-06-28
-
2021-09-04
Dose 3 — Pfizer-BioNTech
- 2021-09-27
- 2021-09-27
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-12-04
-
2022-02-05
Dose 4 — Pfizer-BioNTech
- 2022-03-05
- 2022-05-07
-
2022-08-06
Survey response — 6 months, dose 4MedDRA: COVID-19, Cough, Decreased appetite, Discharge, Fatigue, Headache, Nausea, Oropharyngeal pain, Pyrexia, Respiratory symptom, Respiratory tract congestion, Rhinalgia, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesFree text: July 14 -slightly sore nasopharynx. July 15 PM, full URI symptoms: fever, fatigue, headache, congestion, excessively runny nose & cough (clear discharge), nausea, loss of appetite. Resolved 7/17 AM. Negative Covid 7/15, positive 7/16. 8/1: RCC DxMedDRA releases: 2024-11 · check-in free text available
- 2023-02-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-09-04 | Pfizer-BioNTech | No |
| 4 | 2022-02-05 | Pfizer-BioNTech | No |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Feeling great! So grateful for the vaccine.
Systemic reaction (other): None
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Slightly sore are on March 30
Release 8 — day 35, dose 2
Symptoms: I had a rash on various parts of my body on April 26 - 30. I believe it was a mild viral infection. My spouse had the same symptoms about 6 days after my symptoms. OTC cortisone relieved symptoms (itching, redness).
Release 12 — 6 months, dose 4
Symptoms: July 14 -slightly sore nasopharynx. July 15 PM, full URI symptoms: fever, fatigue, headache, congestion, excessively runny nose & cough (clear discharge), nausea, loss of appetite. Resolved 7/17 AM. Negative Covid 7/15, positive 7/16. 8/1: RCC Dx
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Discharge | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinalgia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Self-medication | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release